Literature DB >> 11897705

Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells.

Wenhan Chang1, Chialing Tu, Stacy Pratt, Tsui-Hua Chen, Dolores Shoback.   

Abstract

Previous studies in chondrogenic RCJ3.1C5.18 (C5.18) cells showed that growth of these cells at high extracellular Ca(2+) concentrations ([Ca(2+)](o)) reduced the expression of markers of early chondrocyte differentiation. These studies addressed whether raising [Ca(2+)](o) accelerates C5.18 cell differentiation and whether Ca(2+) receptors (CaRs) are involved in coupling changes in [Ca(2+)](o) to cellular responses. We found that high [Ca(2+)](o) increased expression of osteopontin (OP), osteonectin, and osteocalcin, all markers of terminal differentiation, in C5.18 cells and increased the production of matrix mineral. Overexpression of wild-type CaR cDNA in C5.18 cells suppressed proteoglycan synthesis and aggrecan RNA, two early differentiation markers, and increased OP expression. The sensitivity of these parameters to changes in [Ca(2+)](o) was significantly increased, as indicated by left-shifted dose-responses. In contrast, stable expression of a signaling-defective CaR mutant (Phe707Trp CaR) in C5.18 cells, presumably through dominant-negative inhibition of endogenous CaRs, blocked the suppression of aggrecan RNA levels and proteoglycan accumulation and the enhancement of OP expression by high [Ca(2+)](o). These data support a role for CaRs in mediating high [Ca(2+)](o)-induced differentiation of C5.18 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897705     DOI: 10.1210/endo.143.4.8709

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

Review 1.  The biology and pathology of vitamin D control in bone.

Authors:  Taison D Bell; Marie B Demay; Sherri-Ann M Burnett-Bowie
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 2.  Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development.

Authors:  Yongmei Wang; Daniel D Bikle; Wenhan Chang
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

Review 3.  The calcium-sensing receptor in bone.

Authors:  Toru Yamaguchi
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 4.  Cell culture systems for studies of bone and tooth mineralization.

Authors:  Adele L Boskey; Rani Roy
Journal:  Chem Rev       Date:  2008-09-19       Impact factor: 60.622

Review 5.  The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

Authors:  David Goltzman; Geoffrey N Hendy
Journal:  Nat Rev Endocrinol       Date:  2015-03-10       Impact factor: 43.330

6.  Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background.

Authors:  Qisheng Tu; Min Pi; Gerard Karsenty; Leigh Simpson; Shiguang Liu; L Darryl Quarles
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

7.  The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone.

Authors:  Claudine H Kos; Andrew C Karaplis; Ji-Bin Peng; Matthias A Hediger; David Goltzman; Khalid S Mohammad; Theresa A Guise; Martin R Pollak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 8.  The calcium-sensing receptor in bone metabolism: from bench to bedside and back.

Authors:  L Cianferotti; A R Gomes; S Fabbri; A Tanini; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-23       Impact factor: 4.507

Review 9.  The role of the calcium-sensing receptor in bone biology and pathophysiology.

Authors:  T A Theman; M T Collins
Journal:  Curr Pharm Biotechnol       Date:  2009-04       Impact factor: 2.837

10.  The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.

Authors:  Wenhan Chang; Chialing Tu; Tsui-Hua Chen; Daniel Bikle; Dolores Shoback
Journal:  Sci Signal       Date:  2008-09-02       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.